Thiosugars have attracted much attention in the field of pharmaceuticals because of their excellent biological activities, and chemical synthesis is an important way to obtain thiosugars. Using 6-O-diphenylphosphoryl-3,4-O-carbonate-D-galactal and thiophenols as starting materials, the regio-and stereo-selective syntheses of 1β-/(3R)-aryl thiosugars were controlled with NiBr2 and Pd2(dba)3 catalysts, respectively. The structures of the target compounds were characterized by nuclear magnetic resonance, high-resolution mass spectrometry and single crystal X-ray diffraction. This method exhibited favourable compatibility with various functional groups substituted thiophenols, which could be used for the structural modification of active natural products. The research work is help for the rapid construction of the compound library of 1β-/(3R)-aryl thiosugars for drug discovery. Keywords Pd catalysis; Ni catalysis; D-galactal; thiosugar; synthesis 近年来, 糖类化合物作为生物成像的载体 [1] 、修饰 DNA 和蛋白质的重要物质 [2] 和细胞培养保存的介质 [3] , 在生物领域被广泛研究. 硫代糖类化合物作为氧糖苷的 类似物, 具有更广泛的生物活性和更好的稳定性. 细胞 表面的一些糖类承担着免疫识别的重要作用, 硫代糖已 经被证明是酶系统中碳水化合物与蛋白质之间相互作 用的重要工具 [4] . 硫代低聚糖 S-Galp(α1→3)Galp 还可作 为在锥形虫细胞表面被溶菌抗体识别的拟糖 [5] (图 1). 药 物和天然产物的糖基化修饰具有重要意义 [6][7] , 例如 3-硫代糖修饰的蛋白质可有效应用于细胞标记 [8][9] ; 胰高 血糖素样态 1 (GLP-1)经过硫代糖的修饰后, 其生物活 性和抗酶解性都得到了显著的提升 [10] ; 硫代糖类能用 于治疗糖尿病 [11] 和调控植物细胞代谢 [12] . 此外, 硫代糖 还作为合成低聚寡糖的重要中间体而被广泛研究 [13][14] . 许多已在市售或正在研发中的硫代糖类药物, 如金诺芬 (Auranfin) [15][16][17] 、芸苔葡糖硫苷(Glucosinolate) [18][19][20] 和吡 利霉素(Pirlimycin) [21][22] 等(图 1)展现出了抗风湿炎症、 抗 癌特性及治疗神经系统疾病等效果.